SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-013309
Filing Date
2024-04-26
Accepted
2024-04-26 08:10:26
Documents
23
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A pbyi20240308_def14a.htm   iXBRL DEF 14A 1408584
6 auerback01.jpg GRAPHIC 8362
7 bodtenure2.jpg GRAPHIC 19695
8 capni2023.jpg GRAPHIC 52222
9 caprev2023.jpg GRAPHIC 57326
10 captsr2023.jpg GRAPHIC 65387
11 pblogo01.jpg GRAPHIC 11354
12 proxypage01.jpg GRAPHIC 137804
13 proxypage02.jpg GRAPHIC 271759
14 yr_ceorealizedgraphrdg.jpg GRAPHIC 31915
  Complete submission text file 0001437749-24-013309.txt   3725835

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20231231.xsd EX-101.SCH 2757
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20231231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20231231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20231231_pre.xml EX-101.PRE 714
26 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20240308_def14a_htm.xml XML 89819
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35703 | Film No.: 24878909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)